CT
EXEL icon

Clearstead Trust’s Exelixis EXEL Stock Holding History

Clearstead Trust’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22K Buy
96
+2
+2% +$97 ﹤0.01% 766
2026
Q1 		$4.03K Hold
94
– – ﹤0.01% 791
2025
Q4 		$4.12K Sell
94
-24
-20% -$993 ﹤0.01% 798
2025
Q3 		$4.87K Sell
118
-10
-8% -$402 ﹤0.01% 770
2025
Q2 		$5.64K Buy
128
+51
+66% +$2.04K ﹤0.01% 725
2025
Q1 		$2.84K Buy
+77
New +$2.74K ﹤0.01% 719

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Trust's EXEL Position: Q2 2026 in Review

Clearstead Trust increased its Exelixis (EXEL) stake by 2.1% in Q2 2026, buying an estimated $97 and bringing the position to 96 shares worth $5.22K. The position accounts for ﹤0.01% of the portfolio, ranked #766.

Clearstead Trust first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.64K in Q2 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Clearstead Trust held 96 shares of Exelixis worth $5.22K as of Q2 2026.
  • Clearstead Trust bought 2 Exelixis shares in Q2 2026, an estimated $97.
  • Exelixis made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #766 holding.
  • Clearstead Trust first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • Clearstead Trust's Exelixis position peaked at $5.64K in Q2 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.